Li Shude, Project Director of BeiGene Ltd
喜康JHL生物制药公司厂长，上海百迈博制药有限公司Biomabs副总裁，梅里亚集团Merial中国区生产项目总监。神隆公司ScinoPharm技术处长, 参与建成了价值2亿美元的全新药厂, 并获得了美国FDA的GMP认证。葛兰素史克公司GSK厂长。上海罗氏Roche副总经理。勃林格殷格翰公司Boehringer Ingelheim厂长，建立全新的GMP生产厂。曾经多次负责药物生产工厂的建设与项目管理。在药厂建设实践中累积了丰富的经验。对制药行业的质量规范、生产运营、供应链体系优化、风险与安全管理,有深入的体会。
He served as the Factory Manager of JHL BIOTECH, INC., the Vice President of Shanghai Biomabs Pharmaceuticals Co., Ltd and the Director of Production Project in China for Merial Group. Also, he served as the Technical Director of ScinoPharm, and has participated in the construction of a new pharmaceutical factory valued about USD 200 million, and obtained the GMP certification from FDA in the United States. He works as the Factory Manager of Glaxosmithkline GSK, and the Vice General Manager of Roche (Shanghai) as well as the Factory Manager of Boehringer Ingelheim, and has constructed a fresh new GMP manufacturing plant. He has been responsible for the construction and project management of the pharmaceutical factories repeatedly. And he has accumulated a wealth of experience from the construction practice of the pharmaceutical factories. Mr Li has an in-depth understanding of the quality norms, production operations, optimization of the supply chain systems, risks and safety management for the pharmaceutical industry.